drug
as of 2026-07-01Pregnenolone
pregnenolone
MeSH D011284
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Sha'ar Menashe Mental Health Center
5 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Trials
5
Efficacy of Pregnenolone in Patients With Schizophrenia
NCT00615511Phase 2Completed
Study of a Neurocognition Enhancing Agent in Patients With Schizophrenia
NCT00894842Phase 2, Phase 3Completed
Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset Schizophrenia
NCT00847600Phase 4Completed
Pilot Study of Pregnenolone Augmentation Targeting Cognitive Symptoms in Persistently Symptomatic Patients With Schizophrenia
NCT00560937—Completed
Pregnenolone in the Management of Schizophrenia Patients
NCT00174889Phase 1Completed
KOLs & investigators
6
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
trial
indication
indication
indication
indication
indication
KOL
Michael S. Ritsner, MD, PhD
personKOL score 5
Christine E Marx, MD, MA
personKOL score 5
Siow Ann Chong
personKOL score —
Jason J Kim, MD
personKOL score —